Probability of Response as Defined by a Clinical Decision Support Tool Is Associated With Lower Healthcare Resource Utilization in Vedolizumab-Treated Patients With Crohn's Disease.

Crohns Colitis 360 · 2022 · PMC9802432 · PMID 36778514

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

did not reach statistical significanceP = .051so close (0.05 < p ≤ 0.1)

This pattern was also observed for the 3-variable CDST in the Optum data set ( Figure 2 ), although for ED visits, the modified CDST did not reach statistical significance ( P = .051).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.